AI-BASED Tool to Estimate Sodium Intake in STAGE 3 to 5 CKD Patients—The UniverSel Study
Nutrients · 2025
DOI: 10.3390/nu17213398 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Nutrients, 2025. Verfasst von Maelys Granal und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hospices Civils de Lyon, Hôpital Edouard Herriot, Service de Néphrologie, Université Claude Bernard Lyon 1, 69003 Lyon, France. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Sodium, Dietary. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Arterial hypertension is highly prevalent among patients with chronic kidney disease (CKD), acting both as a cause and consequence of declining kidney function, and significantly increasing cardiovascular risk. Among modifiable risk factors, diet—particularly excessive sodium intake—plays a central role in the prevention and personalized management of CKD.
Methods
This study aimed to develop an innovative, digitally accessible tool to estimate sodium intake in stages 3 to 5 CKD patients, using 24-h urinary sodium excretion as the reference standard.
Results
Twenty-five clinical, biological, therapeutic, and dietary variables were collected from 493 patients followed across 6 French centers. A probabilistic Tree-Augmented Naive Bayes model was used to develop the tool based on the 15 most informative variables. The model demonstrated an internal accuracy of 71%, indicating that predicted and observed sodium intake categories matched in 71% of cases.
Conclusions
This AI-based prediction model offers a promising clinical tool to estimate daily sodium intake in patients with stages 3 to 5 CKD. However, external validation using independent national and international datasets is essential to establish its robustness and generalizability prior to implementation in routine clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospices Civils de Lyon, Hôpital Edouard Herriot, Service de Néphrologie, Université Claude Bernard Lyon 1, 69003 Lyon, France.
- Laboratoire de Biométrie et Biologie Evolutive, Equipe EMET Equipe Evaluation et Modélisation des Effets Thérapeutiques, Université Claude Bernard Lyon 1, 69100 Villeurbanne, France.
- Department of Nephrology, Hôpitaux Universitaires de Strasbourg, 1 Place de l'Hôpital, 67000 Strasbourg, France.
- Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Université de Lyon, Service de Néphrologie, Carmen, 69495 Pierre-Bénite, France.
- CarMeN Laboratory, INSERM 1060, INRAE, Claude Bernard Lyon 1 University, 69310 Pierre-Bénite, France.
- Physiology Department, ESH Hypertension Excellence Centre Bichat Hospital, AP-HP, Université Paris Cité, Inserm U1148, LVTS, 75018 Paris, France.
ORCID-Profile: Nans Florens, Denis Fouque, Laetitia Koppe, Emmanuelle Vidal-Petiot
Zitieren
APA
Granal, M., Florens, N., Younes, M., Fouque, D., Koppe, L., Vidal-Petiot, E., Duly-Bouhanick, B., Cartelier, S., Sens, F., & Fauvel, J. P. (2025). AI-BASED Tool to Estimate Sodium Intake in STAGE 3 to 5 CKD Patients—The UniverSel Study. Nutrients. https://doi.org/10.3390/nu17213398
Vancouver
Granal M, Florens N, Younes M, Fouque D, Koppe L, Vidal-Petiot E, et al. AI-BASED Tool to Estimate Sodium Intake in STAGE 3 to 5 CKD Patients—The UniverSel Study. Nutrients. 2025. doi:10.3390/nu17213398
BibTeX
@article{Granal2025,
author = {Granal, Maelys and Florens, Nans and Younes, Milo and Fouque, Denis and Koppe, Laetitia and Vidal-Petiot, Emmanuelle and Duly-Bouhanick, Béatrice and Cartelier, Sandrine and Sens, Florence and Fauvel, Jean-Pierre},
title = {AI-BASED Tool to Estimate Sodium Intake in STAGE 3 to 5 CKD Patients—The UniverSel Study},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17213398}
}
EUVIMED